bropirimine and liarozole

bropirimine has been researched along with liarozole* in 1 studies

Reviews

1 review(s) available for bropirimine and liarozole

Article	Year
[Development of new drugs for urological cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13 Urological cancers have a variety of biological characteristics. Thus, anti-cancer agents in this field are often developed focusing on the biological characteristics. For example, LH-RH agonist and anti-androgens have been developed for androgen-sensitive prostate cancer, interferons and IL-2 for renal cell cancer, and BCG for superficial bladder cancer. In this manuscript, new agents which are thought to be promising in the urological field, bropirimine for bladder cancer and liarozole for prostate cancer, are briefly introduced. Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Cytosine; Humans; Imidazoles; Kidney Neoplasms; Male; Prostatic Neoplasms	1997

Article

Year

[Development of new drugs for urological cancers].

Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13

Urological cancers have a variety of biological characteristics. Thus, anti-cancer agents in this field are often developed focusing on the biological characteristics. For example, LH-RH agonist and anti-androgens have been developed for androgen-sensitive prostate cancer, interferons and IL-2 for renal cell cancer, and BCG for superficial bladder cancer. In this manuscript, new agents which are thought to be promising in the urological field, bropirimine for bladder cancer and liarozole for prostate cancer, are briefly introduced.

Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Cytosine; Humans; Imidazoles; Kidney Neoplasms; Male; Prostatic Neoplasms

1997